We also found no strong evidence that insulin treatment is associated with clinicopathological subtypes; though the poor-prognosis tumors were more often occurring in premenopausal women with diabetes not using insulin and in type 1 diabetes insulin users. This evidence concerns the gene INS and diabetes mellitus.